Ashley T. Munchel, Md
University of Maryland Medical Center
United States of America
2002 B.A. Biology, University of Virginia, Charlottesville, VA 2006 M.D. Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA Post Graduate Education and Training 2006-2009 Internship and residency, Pediatrics, Jackson Memorial Hospital, Miami, FL 2009-2012 Fellowship, Pediatric Hematology/Oncology, Johns Hopkins Hospital/National Cancer Institute Combined Fellowship, Baltimore/ Bethesda, MD 2015 Observorship, Pediatric Blood and Marrow Transplantation, Children’s Hospital of Philadelphia, Philadelphia, PA
I am the director of Pediatric Blood Marrow Transplantation. Addtionally, I care for patients with a variety of malignant and non-malignant blood disorders and solid tumors. Share
Munchel A, Kesserwan C, Symons H, Kasamon Y, Jones R, Fuchs E. Nonmyeloablative, HLA-haploidentical bone marrowtransplantation with high dose, post-transplantation cyclophosphamide. Pediatric Reports. 2011; 3: (s2)e15.
Munchel A, Chen A, Symons H. Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient. Clinical Pediatric Emergency Medicine. 2011; 12: 233-244.
Munchel A, Kasamon Y, Fuchs E. Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrowtransplantation and high dose, post-transplantation cyclophosphamide. Best Practice and Research Clinical Haematology. 2011; 24: 359-368